We then performed qPCR on the total RNA from the 20 BRG1-negative and 20 BRG1-positive tumor specimens and found that BRG1 loss was statistically associated with E-cadherin loss (4-fold difference) in these primary tumors (two-tailed t-test, p = 1.9E-03). Here, SMARCA4 is linked to neoplasm.